Albireo pharma, inc. (ALBO)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Jun'10
Revenue

10,615

9,636

3,776

2,628

2,108

12,740

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

11,241

11,364

8,125

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

Operating expenses:
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Research and development

53,376

45,575

40,863

38,533

33,910

31,732

26,219

19,779

16,330

12,991

10,705

9,541

9,292

8,077

7,966

7,891

10,232

11,552

13,365

13,946

12,520

13,860

14,194

14,806

14,652

13,361

14,296

15,479

14,961

14,638

12,315

10,201

10,186

10,445

13,597

17,238

0

0

0

Government grants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

531

827

625

447

546

0

0

0

-

-

0

0

-

-

-

-

-

General and administrative

25,823

22,963

22,633

20,473

19,226

18,061

16,828

16,687

16,162

15,246

20,740

18,377

17,692

15,786

7,312

7,399

5,896

6,201

6,402

6,092

5,915

6,035

5,598

5,947

6,367

6,810

6,843

6,817

6,825

6,481

7,072

7,987

8,593

9,068

9,625

10,044

0

0

0

Other operating expense, net

-6,730

-2,210

-5,779

-1,150

-1,629

-837

1,890

1,677

2,229

3,659

790

331

-24

205

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

85,929

70,748

69,275

60,156

54,765

50,630

41,157

34,789

30,263

24,578

30,655

27,587

27,008

23,658

15,471

15,425

15,973

17,753

19,767

20,038

18,208

19,461

19,261

19,926

20,394

19,724

20,593

21,958

21,473

20,835

19,299

18,188

18,779

19,513

23,222

27,282

0

0

0

Operating loss

-75,314

-61,112

-65,499

-57,528

-52,657

-37,890

-28,989

-22,858

-19,061

-24,577

-27,414

-24,318

-15,767

-12,294

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense, net

-5,925

-5,296

-4,723

-4,816

-5,131

-4,838

-3,631

-2,241

-727

40

-151

-682

-1,042

-1,319

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-operating income (expense), net

-

-

-

-

-

-3,363

-2,471

-2,478

638

335

-2,951

-3,035

-2,911

-2,675

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

264

267

273

60

52

43

36

42

49

57

57

56

56

63

67

72

80

86

91

79

60

33

0

0

0

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

0

-

-

Adjustments to fair value of common stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

176

299

465

1,009

2,230

3,659

3,067

5,107

7,244

1,265

1,575

1,217

-2,475

601

863

-1,510

7,367

10,077

9,694

12,611

0

0

0

-

Loss on settlement of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

-

-

-

Net loss before income taxes

-

-

-

-

-

-

-

-

-19,150

-24,202

-30,516

-28,035

-19,720

-16,288

-8,337

-7,533

-16,114

-17,230

-18,708

-17,765

-14,513

-16,352

-14,105

-12,625

-19,072

-18,093

-19,320

-24,370

-20,805

-19,900

-20,729

-10,735

-8,611

-9,740

-10,551

-23,359

0

0

0

Income tax

-

-

-

-

-

-

-

-

212

212

62

62

62

62

8

14

34

35

29

26

20

23

26

35

15

16

15

29

14

15

18

1

48

45

41

-6

0

0

0

Net loss

-77,548

-62,717

-71,059

-63,174

-61,149

-46,111

-35,303

-27,789

-19,362

-24,414

-30,578

-28,097

-19,782

-16,350

-8,345

-7,547

-16,148

-17,265

-18,737

-17,791

-14,533

-16,375

-14,131

-12,660

-19,087

-18,109

-19,335

-24,399

-20,819

-19,915

-20,747

-10,736

-8,659

-9,785

-10,592

0

0

0

-

Net loss per share - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13.32

7.42

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13.32

0.69

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

302

288

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

302

3,101

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share attributable to holders of common stock:
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Charge for accretion of beneficial conversion rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

-

-

-

Deemed dividend - warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

-

-

-

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-20,819

-19,915

-20,747

-10,736

-8,659

-9,785

-10,592

-23,353

0

0

0

Net loss per common share - basic and diluted

-2.23

-0.57

-1.73

-1.35

-1.39

-1.40

-1.17

-1.22

-0.15

-0.47

-0.73

-0.86

-1.06

-6.79

-6.26

12.06

-12.20

-0.05

-13.20

-0.12

-0.18

-0.20

-0.10

-0.15

-0.29

-0.12

0.05

-0.66

-0.37

-0.26

-0.47

-0.52

-0.45

-0.47

-0.47

-0.48

-0.21

-0.20

-0.36

Weighted-average shares outstanding:
Weighted-average common shares used to compute basic and diluted net loss per common share

14,132

12,708

12,685

12,355

12,001

12,006

11,969

11,938

10,896

8,934

8,878

7,171

6,292

60,007

-183,340

128,026

265

63,583

-96,229

53,893

24,369

23,435

22,341

21,118

21,083

21,073

19,670

14,573

14,182

14,176

12,568

11,600

9,688

9,673

-

8,254

26,469

-

-

Weighted average shares outstanding - basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26,419

23,944